ELSIconversations ELSICon2022: Access to Genetic Screening and Therapies: Case Study of Sickle Cell Disease
Co-Moderators: Liza Johnson, MD, MPH, MSB & Mildred Cho, PhD
Presenters: Jeanne O'Brien, MD, MSc & Joshua Combs, MD, FACOG
Link to pre-recorded video: Will it be easier to cure sickle cell disease through gene therapy than prevent the disease through pre-implantation genetic testing for the selection of unaffected embryos?
This series includes selected recordings from the 2022 ELSI Congress, grouped by topic into four one-hour discussion and networking sessions. The presentation authors will briefly recap their research at each session, followed by moderated discussion and audience Q&A.
Suggested citation: O'Brien, J., Combs, J. & Johnson, L., Cho, M. (2023, February 15). Access to genetic screening and therapies: Case study of sickle cell disease [Video]. The Center for ELSI Resources and Analysis (CERA). https://elsihub.org/video/elsiconversations-elsicon2022-access-genetic-screening-and-therapies-case-study-sickle-cell
Tags
Videos in Series
-
ELSIconversations 3: ELSIcon2022 - ELSIconversations ELSICon2022: The All of Us Research Program: What Duties do Researchers Have When Conducting Precision Medicine Research?
-
ELSIconversations 3: ELSIcon2022 - ELSIconversations ELSICon2022: Stakeholder Perspectives on Data Sharing and Privacy
-
ELSIconversations 3: ELSIcon2022 - Investigating an Ethos of Duty in Precision Medicine Research Calls for Minority Participation
-
ELSIconversations 3: ELSIcon2022 - White racial framing and comfort with medical research: a critical analysis
-
ELSIconversations 3: ELSIcon2022 - A Survey on Public Perception toward the Korean National Bio Big Data Project
-
ELSIconversations 3: ELSIcon2022 - ELSI and the New Precision Stewards?
